financetom
Business
financetom
/
Business
/
Midstream operator ONEOK beats Q3 profit estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Midstream operator ONEOK beats Q3 profit estimates
Oct 28, 2025 1:54 PM

Overview

* ONEOK ( OKE ) Q3 net income rises to $940 mln, adjusted EBITDA beats analyst expectations

* Adjusted EPS for Q3 beats consensus, driven by acquisition integration and volume growth

* Company repurchased 611,237 shares for $45 mln under $2 bln share buyback program

Outlook

* ONEOK ( OKE ) affirms 2025 net income and adjusted EBITDA guidance ranges

* In August company announced plans to construct Bighorn plant, enhancing future capacity

Result Drivers

* VOLUME GROWTH - 17% increase in Rocky Mountain region NGL raw feed throughput and 6% increase in Mid-Continent region NGL raw feed throughput contributed to results

* ACQUISITION INTEGRATION - EnLink and Medallion acquisitions positively impacted adjusted EBITDA across segments

* SYNERGY CAPTURE - Synergy capture ahead of expectations, contributing to financial performance

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 EPS Beat $1.49 $1.44

(14

Analysts

)

Q3 Net $940 mln

Income

Q3 Beat $2.11 $2.10

Adjusted bln bln (17

EBITDA Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 10 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the oil & gas transportation services peer group is "buy"

* Wall Street's median 12-month price target for ONEOK Inc ( OKE ) is $90.00, about 23% above its October 27 closing price of $69.29

* The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stryker Unusual Options Activity
Stryker Unusual Options Activity
Mar 15, 2024
High-rolling investors have positioned themselves bearish on Stryker , and it's important for retail traders to take note. This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in SYK often signals that someone has privileged information. Today, Benzinga's options scanner spotted 10...
Artis Real Estate Investment Trust Announces Quarterly Cash Distribution
Artis Real Estate Investment Trust Announces Quarterly Cash Distribution
Mar 15, 2024
04:06 PM EDT, 03/15/2024 (MT Newswires) -- Artis Real Estate Investment Trust (AX-PR-E.TO) announced Friday that its trustees have declared a quarterly cash distribution of $0.449875 per Series E preferred unit of Artis for the quarter ending March 31, 2024. The cash distributions will be made on March 29, 2024, to Series E Unitholders of record on March 29, 2024....
Globalstar Insider Bought Shares Worth $960,300, According to a Recent SEC Filing
Globalstar Insider Bought Shares Worth $960,300, According to a Recent SEC Filing
Mar 15, 2024
04:05 PM EDT, 03/15/2024 (MT Newswires) -- James F Lynch, Director, on March 13, 2024, executed a purchase for 660,000 shares in Globalstar ( GSAT ) for $960,300. Following the Form 4 filing with the SEC, Lynch has control over a total of 13,174,388 shares of the company, with 833,668 shares held directly and 12,340,720 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1366868/000136686824000042/xslF345X03/wk-form4_1710532923.xml...
Regeneron Pharmaceuticals Insider Sold Shares Worth $5,531,290, According to a Recent SEC Filing
Regeneron Pharmaceuticals Insider Sold Shares Worth $5,531,290, According to a Recent SEC Filing
Mar 15, 2024
04:07 PM EDT, 03/15/2024 (MT Newswires) -- Andrew J Murphy, Executive Vice President, Research, on March 13, 2024, sold 5,783 shares in Regeneron Pharmaceuticals ( REGN ) for $5,531,290. Following the Form 4 filing with the SEC, Murphy has control over a total of 52,616 shares of the company, with 48,306 shares held directly and 4,310 controlled indirectly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved